Form C-U Novuson Surgical, Inc.

  
    C-U
    
      
        
          0001655934
          XXXXXXXX
        
        020-29919
      
      LIVE
      
        false
        false
        false
      
    
  
  
    
      At the close of the offering, the issuer closed on $56,093.53 and 97,485 number of securities.
      
        Novuson Surgical, Inc.
        
          Corporation
          WA
          02-13-2014
        
        
          11824 NORTH CREEK PARKWAY NORTH
          SUITE 103
          BOTHELL
          WA
          98011
        
        www.novuson.com
      
      N
      StartEngine Capital, LLC
      0001665160
      007-00007
    
    
      7 - 13 percent
      We charge 2% commission paid in equity or securities at the same rate as this offering.
      Common Stock
      15625
      0.64000
      N/A
      10000.00
      Y
      Other
      At issuer's discretion, with priority given to StartEngine Owners
      1070000.00
      06-29-2022
    
    
      7.00
      61579.00
      428635.00
      12539.00
      347061.00
      0.00
      0.00
      682501.00
      43858.00
      170000.00
      45602.00
      9432.00
      0.00
      0.00
      0.00
      0.00
      1801.00
      -1130587.00
      -733033.00
      AL
      AK
      AZ
      AR
      CA
      CO
      CT
      DE
      DC
      FL
      GA
      HI
      ID
      IL
      IN
      IA
      KS
      KY
      LA
      ME
      MD
      MA
      MI
      MN
      MS
      MO
      MT
      NE
      NV
      NH
      NJ
      NM
      NY
      NC
      ND
      OH
      OK
      OR
      PA
      PR
      RI
      SC
      SD
      TN
      TX
      UT
      VT
      VA
      WA
      WV
      WI
      WY
    
    
      
        Novuson Surgical, Inc.
        Stuart Mitchell
        CEO, Chairman, President, CTO
      
      
        
          Stuart Mitchell
          CEO, Chairman, President, CTO
          07-01-2022
        
        
          Carla Corkern
          Director
          07-01-2022
        
        
          Sam Liao
          Director
          07-01-2022
        
      
    
  

You May Also Be Interested In

• DeepL Launches New AI-powered Offering, DeepL Write Pro, to Supercharge Business Communication
• Form 8.3 - Mattioli Woods
• GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar